Irish M&A activity up 4% in first half of 2025 despite global challenges
It marks a 4% rise in transaction volume compared to the same period in 2024, while total deal value fell to €8.8bn, which reflected a more than 50% decline year-on-year. The law firm said this was underpinned by a slowdown in large-cap and transformational transactions.
However, the volume growth signals continued appetite for strategic acquisitions and investments in the Irish market, William Fry said.
Mid-market size deals continue to dominate, with 88% of disclosed deal values ranging between €5m and €250m, the report found.
Meanwhile, transformational deals, which are deals valued at more than €500m, matched figures from the first half of 2024.
The largest deal of the period was the €1.9bn acquisition of Nordic Aviation Capital A/S by Dubai Aerospace Enterprise Ltd, a subsidiary of the Investment Corporation of Dubai (ICD).
Some 63% of Irish deals involved overseas bidders, up from 57% in the first half of 2024, with strong activity from the US, UK and Norway.
Meanwhile, private equity accounted for 24% of Irish deals, with deal volume up 39% year-on-year. However, the aggregate value of those deals fell by 71%.
The first quarter of 2025 showed to be particularly strong, with 138 deals worth €6.3bn. This represented a 30% growth in volume and 48% in value compared to the first three months of 2024.
Inbound M&A activity continues to dominate, accounting for 63% of all Irish deals in the first half of 2025, up from 57% in the same period last year.
A total of 148 inward investment transactions were announced, including 83 in the first quarter alone, the highest quarterly total in five years. Overseas bidders led 15 of the top 20 deals, with strong participation from the traditional jurisdictions of US and UK as well as Norway, which was involved in two of the largest transactions, the report said.
Private equity firms announced 57 deals in the first half of 2025, a 39% year-on-year increase in volume, though overall deal value fell to €4.2bn, down from €14.6bn in the same period in 2024, which was bolstered by megadeals such as Apollo's investment in Intel's Fab 34.
'Irish M&A activity remains resilient despite global challenges, with a modest increase in deal volume in the first half of 2025," said Andrew McIntyre, Head of Corporate/M&A at William Fry.
"While deal values moderated due to fewer large transactions, the data highlights the strength of Irish assets. International interest is strong, and private equity is showing renewed momentum in the mid-market. Overall, these trends suggest Ireland is well-positioned for continued deal making in the second half.'
Looking ahead, Mr McIntyre said there was a "cautious optimism" for continued M&A activity, supported by projected GDP growth, ECB rate cuts, and momentum in key sectors like renewables and digital transformation.
"Ireland's new FDI screening regime has had minimal impact so far on inbound M&A," he added.
"However, geopolitical risks - especially in the Middle East, Eastern Europe, and the US -remain elevated.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RTÉ News
40 minutes ago
- RTÉ News
Trump says he will use import restrictions to reduce drug prices
US President Donald Trump said he would use import restrictions to force foreign suppliers to cut drug prices and that pharmaceutical companies would have a lot of problems if they did not agree to bring prices down. Speaking at the White House at an event with Republican politicians, Mr Trump pledged to reduce what consumers must pay for prescription drugs. The US is the biggest market by sales for big pharma companies, and Europe and the US have interconnected supply chains for medicines with the pharmaceutical sector employing around 45,000 people in Ireland. Total Irish exports were valued at €223.8 billion last year, with roughly one third going to the US. Of the €72.6 billion in US imports from Ireland, approximately €58 billion relates to pharmaceuticals and chemicals leaving Ireland. Pharmaceutical companies have previously expressed concern about the threat of tariffs and what they would mean for investment in Europe. In April, a number of pharmaceutical companies sent a letter to EU Commission President Ursula von der Leyen, warning that the EU could lose €100bn in new investment unless there is a rethinking on regulation and pricing. The letter was sent by around 30 CEOs of some of the largest pharmaceutical companies in the world.
Irish Examiner
3 hours ago
- Irish Examiner
Davy to focus more investment on European markets amid volatility in US
Despite the fallout from US president Donald Trump's trade war being 'much milder' than expected, Irish wealth management firm Davy still plans to 'bias away' from US markets as high valuations make it 'more vulnerable to correction if the economic picture changes'. In the firm's latest Wealth View report for the third quarter of the year, it noted that US equity markets have rebounded from the turbulence caused by Mr Trump's tariff announcement on April 2 and that Europe has shown strength with markets across the bloc ahead of where they were last year. It attributed the rebound in the US markets to investor confidence that the administration would retreat from policies that disrupt the market, and by optimism surrounding the stimulative effects of the One Big Beautiful Bill Act passed recently by the US Congress. The report said that the economic fallout from the trade war has been 'much milder' than expected 'as tariffs have been paused or have yet to make an impact'. 'Unfortunately, the better-than-expected news is mostly factored into equity valuations already, which have recovered rapidly to multi-year highs, led by the US and the tech sector,' the report said. We note that high valuations are not enough to move markets on their own, but they do make a market more vulnerable to correction if the economic picture changes. "For this reason, we maintain our bias away from the US and towards Europe and emerging markets.' Davy said that the eurozone and China are currently doing better than forecasted but the UK remains in a tight spot. The rising value of the euro against the dollar has also been a significant development for investors this year, according to Davy. However, it cautioned that too strong a euro could cause issues for the European Central Bank (ECB). 'A weaker dollar will push up prices in the US just when tariffs may be doing the same. Also, foreign central banks may push back if the exchange rate interferes with their mandates. For example, the ECB has identified €1.20 as a threshold for concern for the euro-dollar exchange rate,' the report said. The report said that while the S&P 500 hit new highs in June, it has delivered negative returns, after accounting for the depreciation of the dollar. In the first half of the year, the European Stoxx 600 index beat the S&P 500 by the biggest margin this century. Chief investment officer at Davy, Donough Kilmurray, said the last six months show the importance of diversification across investment portfolios. 'We are investing through a period of unusually high uncertainty, and all sorts of assets have played a role already this year, from less-favoured equities to alternative strategies to gold, both by adding to returns and by cushioning declines,' he said. 'Given the incumbent in the White House, we intend to stay diversified.' In a bid to protect against this volatility, Davy has made changes to its Strategic Asset Allocation (SSA) which shifts how it manages long-term portfolios. These include reducing equity exposure in cautious and moderate portfolios, increasing allocation to bonds to help protect against market volatility and macroeconomic risks, as well as increasing the use of alternative investments, including hedge fund-style strategies and gold. Read More Irish economy to grow by more than 4% through 2027 despite heightened geopolitical tensions
RTÉ News
3 hours ago
- RTÉ News
Government to review work permit occupations lists
The Government has announced the opening of a consultation period to allow stakeholders make submissions on the work permit occupations lists. The Critical Skills Occupations List consists of jobs that are in short supply in Ireland and across the European Economic Area (EEA) including roles in areas such as medicine, ICT, sciences, finance and business. The Ineligible Occupations List consists of occupations for which there is an adequate supply of labour and skills, and for which an employment permit will not be issued. The last review of the occupations lists took place in 2023, and resulted in 11 additional roles being placed on the Critical Skills Occupations List, and 32 roles being made eligible for a General Employment Permit. As part of the review process, submissions are sought from employers, representative bodies, Government departments, agencies, and other interested parties relating to occupations currently included on or absent from the lists. "At a time of full employment, with over 2.81 million people at work, and with 90,000 new jobs created in the last year, it is vital that we continue to have a strong and flexible employment permits system to allow non-EEA nationals to fill the skill and labour gaps we cannot access in Ireland or Europe and to ensure our economy remains competitive," Peter Burke, Minister for Enterprise, Tourism and Employment said. "As demonstrated by the changes made to the employment permit system over the last year, the system is responsive to the needs of the sectors and industries it serves," he added. Alan Dillon, Minister of State for Small Business, Retail and Employment, said that non-EEA nationals that fill skills and labour gaps in the domestic economy are a vital part of the Irish economy. "Where employers or stakeholders are facing challenges in recruiting a specific occupation and believe it should be eligible for an employment permit, or believe a certain occupation should move onto the critical skills list, now is their opportunity to share this feedback," Mr Dillon said. Submissions will be accepted through an online consultation form on the Department of Enterprise website and will be open until 19 September.
